Corpus Intelligence IC Memo — PHILIP HEALTH SERVICES INC 2026-04-26 08:08 UTC
IC Memo — PHILIP HEALTH SERVICES INC
Investment Committee Memorandum | SD | 18 beds | Grade D | EBITDA uplift $1.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

PHILIP HEALTH SERVICES INC

CCN 431319 | HAAKON, SD | 18 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

PHILIP HEALTH SERVICES INC is a 18-bed rural/critical access in HAAKON, SD with $17.6M in net patient revenue and a 1.9% operating margin. The hospital serves a payer mix of 86.8% Medicare, 0.6% Medicaid, and 12.5% commercial.

Thesis: Turnaround. Our ML models identify $1.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 1.9% to 9.3% (+736bps).

Net Revenue HCRIS$17.6M
Current EBITDA COMPUTED$336K
Operating Margin COMPUTED1.9%
Occupancy HCRIS50.0%
Revenue / Bed COMPUTED$976K
Net-to-Gross HCRIS72.3%
Distress Probability ML54.6%

2. Market Context & Competitive Position

63
SD Hospitals
-3.2%
State Median Margin
40
Comparable Hospitals

SD has 63 Medicare-certified hospitals with a median operating margin of -3.2%. The target's margin of 1.9% places it above the state median. Among 40 size-comparable peers (9-36 beds), the median margin is -1.6%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (9-36), prioritizing same-state peers. 40 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PHILIP HEALTH SERVICES INC (Target)SD18$17.6M1.9%
SIOUX FALLS SPECIALTY HOSPITALSD33$138.8M31.7%
AVERA QUEEN OF PEACESD25$122.9M-5.8%
MONUMENT HEALTH SPEARFISH HOSPSD27$116.6M1.9%
BLACK HILLS SURGICAL HOSPITAL SD26$91.1M15.3%
HURON REGIONAL MEDICAL CENTERSD25$49.4M-5.9%
MONUMENT HEALTH STURGIS REGIONSD25$39.1M-3.3%
MADISON REGIONAL HEALTH SYSTEMSD22$33.8M-1.6%
SANFORD MEDICAL CENTER VERMILLSD25$32.0M8.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$369K+210bp18mo
Cost to Collect4.5%2.5%$351K+200bp12mo
Denial Rate Reduction12.0%6.5%$348K+198bp12mo
A/R Days Reduction5200.0%3800.0%$214K+122bp9mo
Clean Claim Rate88.0%96.0%$11K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$369K
Cost to Collect
$351K
Denial Rate Reduction
$348K
A/R Days Reduction
$214K
Clean Claim Rate
$11K
Total EBITDA Uplift$1.3M
Current EBITDA$336K
+ RCM Uplift+$1.3M
Pro Forma EBITDA$1.6M
Current Margin1.9%
Pro Forma Margin9.3%
WC Released (1x)$674K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$517K$15.2M29.31x96.5%
Base (11x exit)10.0x11.0x$517K$16.8M32.57x100.7%
Bull Case9.0x11.0x$465K$21.3M45.72x114.8%
Bull (12x exit)9.0x12.0x$465K$23.3M50.17x118.8%
Bear Case11.0x10.0x$569K$8.5M14.98x71.8%
Bear (11x exit)11.0x11.0x$569K$9.6M16.80x75.8%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 86.8% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
HighElevated distress probabilityModel estimates 54.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 40 hospitals with 9-36 beds
  • Same-state prioritization (n=41)
  • Comp margins: P25=-9.0% / P50=-1.6% / P75=9.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.